ophthalmologytimes1h
Prevent Blindness declares 5th annual Thyroid Eye Disease Awareness Week
Prevent Blindness has designated November 18 to 24, 2024, as the 5th annual Thyroid Eye Disease (TED) Awareness Week. The ...
HCW Biologics, Inc: HCW Biologics Reports Third Quarter 2024 Financial Results and Business Highlights
HCW Biologics Inc. (the "Company" or "HCW Biologics") (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing ...
Cue Biopharma, Inc.: Cue Biopharma Reports Third Quarter 2024 Financial Results and Recent Business Highlights
Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate ...
Idaho family fights for and wins coverage of treatment for daughter’s rare condition | Opinion
It just feels like it didn’t have to come to this. I feel like, as a father, I waited way too long for insurance to give us a ...
precisionmedicineonline7h
After Success in Treating Cancer, CAR T Cells Break Into Autoimmune, HIV, and More
As drugmakers take lessons from oncology in developing CAR T cells for other diseases, they must contend with risks that ...
manilatimes14h
HCW Biologics Reports Third Quarter 2024 Financial Results and Business Highlights
Wong, Founder and CEO of HCW Biologics, stated, "In the third quarter 2024, the Company expanded our product portfolio and ...
Zura Bio Announces Submission of Protocol to U.S. Food and Drug Administration for the Phase 2 Study of Tibulizumab in Adults with Systemic Sclerosis
Zura Bio Limited (Nasdaq: ZURA) ("Zura Bio"), a clinical stage, multi-asset immunology company developing novel dual-pathway ...